The virosomal adjuvanted influenza vaccine. - Wikidata - awgldk - TriplyDB

The virosomal adjuvanted influenza vaccine.

The virosomal adjuvanted influenza vaccine.

http://www.wikidata.org/entity/Q37678409

about

Protection of young children from influenza through universal vaccination.Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.Quantitative review of antibody response to inactivated seasonal influenza vaccines.Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.Present and future of influenza prevention in pediatrics.Liposomal vaccine delivery systems.Influenza virosomes as a vaccine adjuvant and carrier system.Current adjuvants and new perspectives in vaccine formulation.Adjuvanted influenza vaccines.Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Immunological assessment of influenza vaccines and immune correlates of protection.

P2860

Q27693242-CFB32A2D-5FA6-418A-AAC7-D5B69863F2ED Q30353863-95AF68A5-4678-4CDC-AFF3-64EB4DABAD69 Q35218808-78F8CE23-B666-4B13-B838-7A4694AD99A7 Q35874111-5EBE22E3-0D08-4D8B-A4FB-B55053009BBB Q37848838-1637A575-A668-488F-B8D9-2B76FBD415BF Q37854063-51193736-EF56-4459-BD5E-38D933739BB7 Q37867100-54177286-8AD5-4C05-8AAB-54347958FCBD Q37909424-9283FB31-636C-4B19-8FC5-46CE33CCB8E4 Q37976540-E4258189-3C45-4F53-B1FE-1749D946D76E Q38068245-93BB2715-0CC0-428F-8F87-510D3BAC9BE9 Q38105339-98FB33AC-01BB-496F-AEE1-8D4F5E53523B

P2860

The virosomal adjuvanted influenza vaccine.

http://www.wikidata.org/entity/Q37678409

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The virosomal adjuvanted influenza vaccine.

@en

The virosomal adjuvanted influenza vaccine.

@nl

type

label

The virosomal adjuvanted influenza vaccine.

@en

The virosomal adjuvanted influenza vaccine.

@nl

prefLabel

The virosomal adjuvanted influenza vaccine.

@en

The virosomal adjuvanted influenza vaccine.

@nl

P1433

Q37678409-F649D6CA-8127-4E6D-B8DD-C97793AC211E

P1476

Q37678409-AFE2B355-92BF-45EC-A123-57E551E030D0

P2093

Q37678409-35F40114-9D53-4B7F-B29B-A7F378F41996

Q37678409-82415873-0AA8-493A-9CBB-16098B2376C3

P2860

Q37678409-0AFA3D42-1265-43BC-AB43-AD64D6FA9840

Q37678409-0C6872C5-208D-4555-BA5B-FE49F63E2953

Q37678409-0E2731BF-3BF8-4787-A732-8A2DD3208FC6

Q37678409-11375639-4AF7-44D6-ACBC-DE1FB850987D

Q37678409-12BEBE7B-4E7B-421E-BCBF-D111185B7C26

Q37678409-1384EB84-011D-4E7F-A4F7-077905D72A5D

Q37678409-180C5AE0-25ED-4DB5-919A-53590D571EDD

Q37678409-2785140E-1882-4FF9-8BAF-66010AAF8976

Q37678409-333D36BF-7EBD-4960-962C-6154F310F683

Q37678409-33A11C58-20D8-4F8C-B692-E9AD3F75F60E

P304

Q37678409-026990E7-3F0B-400F-B84C-277BBD1AA939

P31

Q37678409-8BF0EB65-5772-43C1-AE05-139643691616

P356

Q37678409-5E8B836C-3209-4BD3-9271-79D9094C3267

P407

Q37678409-D48E22B1-E455-4866-A920-A604766C1188

P433

Q37678409-7BBAF27D-DA98-4064-BE0F-65AC968019D4

P478

Q37678409-1CD4FB8C-2581-40CE-A2E1-997F1234A53A

P577

Q37678409-AF7AC551-DA02-4BB6-947D-D1788D670CA2

P698

Q37678409-33EDB1FD-F4A3-4DDA-B776-F75946FD8DCD

P356

14712590903431014

P1433

Expert Opinion on Biological Therapy

P1476

The virosomal adjuvanted influenza vaccine.

@en

P2093

Gian Vincenzo Zuccotti

http://www.w3.org/2001/XMLSchema#string

Selma Calcagnile

http://www.w3.org/2001/XMLSchema#string

P2860

The virosome concept for influenza vaccines

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

The impact of influenza on the health and health care utilisation of elderly people.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses

Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review.

Influenza vaccination in elderly people.

P304

191-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712590903431014

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20088714

http://www.w3.org/2001/XMLSchema#string